Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

NCT02585713 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
300
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Academic and Community Cancer Research United

Collaborators